| scholarly article | Q13442814 |
| P50 | author | Trevor A Graham | Q39031039 |
| Alan Askari | Q57063410 | ||
| Janindra Warusavitarne | Q57159875 | ||
| Gui H Lee | Q85556616 | ||
| Ailsa Hart | Q92024668 | ||
| P2093 | author name string | Morgan Moorghen | |
| Matthew D Rutter | |||
| Brian P Saunders | |||
| Siwan Thomas-Gibson | |||
| Chang-Ho Ryan Choi | |||
| P2860 | cites work | A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications | Q33965561 |
| Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis. | Q34104498 | ||
| Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis | Q34379786 | ||
| Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology | Q34598411 | ||
| Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis | Q34899413 | ||
| Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. | Q35598279 | ||
| Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment | Q35760612 | ||
| Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? | Q35953822 | ||
| Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining | Q35971561 | ||
| Endoscopic and pathological aspects of colitis-associated dysplasia | Q37601306 | ||
| Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia | Q37786311 | ||
| Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years | Q38433080 | ||
| Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease | Q38450732 | ||
| Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? | Q40619445 | ||
| Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. | Q43441872 | ||
| Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis | Q43703288 | ||
| Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis | Q44655021 | ||
| Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. | Q45204242 | ||
| Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine | Q46321143 | ||
| Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. | Q50714369 | ||
| Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. | Q52932163 | ||
| A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. | Q54784154 | ||
| Clonality, Founder Mutations, and Field Cancerization in Human Ulcerative Colitis–Associated Neoplasia | Q58104226 | ||
| Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps | Q63407681 | ||
| Cancer surveillance in ulcerative colitis | Q70136170 | ||
| Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy | Q71437311 | ||
| Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis | Q83161259 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ulcerative colitis | Q1477 |
| colonoscopy | Q840387 | ||
| P304 | page(s) | 1022-1034 | |
| P577 | publication date | 2015-03-31 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview | |
| P478 | volume | 110 |
| Q99591192 | A Tumbling Magnetic Microrobot System for Biomedical Applications |
| Q41642099 | Advanced imaging in colonoscopy: contemporary approach to dysplasia surveillance in inflammatory bowel disease. |
| Q35771964 | Advances in endoscopic imaging in ulcerative colitis. |
| Q51743145 | An Update on Surveillance in Ulcerative Colitis. |
| Q50020845 | An evolutionary perspective on field cancerization. |
| Q88727939 | Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-Grade Dysplasia in Patients With Inflammatory Bowel Disease |
| Q90339285 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults |
| Q48263345 | Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases |
| Q42738849 | Clarity and caution in the natural history of low-grade dysplasia in ulcerative colitis |
| Q38973304 | Clonal evolution of colorectal cancer in IBD. |
| Q40036304 | Colonoscopy Surveillance and Management of Dysplasia in Inflammatory Bowel Disease |
| Q30245054 | Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management |
| Q92759068 | Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments |
| Q57071771 | DALM, rest in peace: a pathologist's perspective on dysplasia in inflammatory bowel disease in the post-DALM era |
| Q38877426 | DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance |
| Q53085003 | Dysplasia surveillance - a practical guide. |
| Q55185963 | Early detection of ulcerative colitis-associated colorectal cancer. |
| Q48176978 | Editorial: gut selective immunosuppression-is it a double edged sword? |
| Q93048973 | Endocuff Vision is safe to use for dysplasia surveillance in patients with ulcerative colitis: a feasibility study |
| Q90083785 | Endoscopic resection for non-polypoid dysplasia in inflammatory bowel disease: a systematic review protocol |
| Q90055649 | Endoscopic surveillance strategies for dysplasia in ulcerative colitis |
| Q57599267 | Evolutionary history of human colitis-associated colorectal cancer |
| Q50101227 | Getting a Low Grade for Missing High-Grade Dysplasia and Colorectal Cancer in IBD. |
| Q38754533 | How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients |
| Q26774592 | Inflammatory bowel disease associated neoplasia: A surgeon's perspective |
| Q43142124 | Interval colorectal carcinoma: An unsolved debate |
| Q57832665 | Large bowel cancer in the setting of inflammatory bowel disease |
| Q92599664 | Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study |
| Q53216908 | Miles to Go on the SCENIC Route: Should Chromoendoscopy Become the Standard of Care in IBD Surveillance? |
| Q91855441 | Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study |
| Q39380756 | Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: A hospital-based cohort study |
| Q49247828 | Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer |
| Q92293032 | Reflecting on the SCENIC recommendations for chromoendoscopy and targeted biopsy |
| Q48182848 | Results of a 36-year surveillance program for ulcerative colitis-associated neoplasia in the Japanese population. |
| Q91818483 | Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study |
| Q47860432 | Role of SMAD proteins in colitis-associated cancer: from known to the unknown. |
| Q41287600 | Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis |
| Q46893452 | Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis |
| Q47966879 | Strategies for detecting colon cancer in patients with inflammatory bowel disease. |
| Q38533703 | Surveillance colonoscopy for colitis-associated dysplasia and cancer in ulcerative colitis patients |
| Q38748390 | Surveillance strategies for colitis-associated cancer: state of the art and future perspectives |
| Q38775276 | Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia |
| Q49616241 | Targeting Mucosal Endothelin-A-Receptor Expression by Fluorescence Endoscopy is Feasible to Detect and Characterize Colitis-Associated Cancer in Mice |
| Q57652459 | The use of chromoendoscopy for surveillance of inflammatory bowel disease |
| Q92078935 | Ulcerative Colitis: Shifting Sands |
| Q88899916 | Ulcerative colitis |
Search more.